CHD/Prevention News

Markers of subclinical heart damage were observed among individuals who smoke cigarettes, even decades after quitting, according to a study published in the Journal of the American College of Cardiology.

Short sleep duration, with and without self-reported insomnia, was predictive of elevated blood pressure and hypertension among adolescents, a speaker reported.

Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and phentermine/topiramate, but their estimated net price is too high for them to be cost-effective, researchers reported.

Intentional weight loss of 5% or more, coupled with reduced waist circumference was associated with lower risk for death from cancer, CVD or any cause among postmenopausal women followed for more than 18 years, data show.

TV watching in excess of 1 hour per day was associated with increased risk for atherosclerotic heart disease, independent of genetic risk for diabetes, according to new data published in the Journal of the American Heart Association.

Adults with obesity and type 2 diabetes receiving once-weekly combination cagrilintide 2.4 mg and semaglutide 2.4 mg lost 15.7% of their body weight at 68 weeks, according to topline data from the REDEFINE 2 trial.

Slightly elevated blood glucose within a range of what is generally considered “normal” may be associated with increased risk for heart disease, researchers reported.

Adults with obesity who have a prescription for Wegovy but do not have insurance coverage for the drug can now purchase the medication through a new Novo Nordisk direct-to-consumer program.

Visualizing and explaining patients’ risk for coronary artery disease using coronary CT and coronary calcium scoring may improve statin adherence and subsequently lower risk for future CAD events, researchers reported.